Skip to content
Congress·In Committee·7 months ago

Congress Proposes $2 Million Daily Fines for Drug Makers Blocking Discounts to Health Clinics

Also known as: 340B PATIENTS Act of 2025

Legislative Progress

✓ Filed
Review
House
Senate
President

Impacts

Positive Impacts(5)
Medicaid
Helps

Strengthens the 340B program tied to Medicaid, ensuring drug discounts reach more patients at safety-net clinics and hospitals.

Medicare
Helps

Protects Medicare-linked 340B discounts by preventing drug makers from blocking contract pharmacy arrangements.

Chronic Illness
Helps

Patients with cancer, MS, and other serious conditions gain better access to discounted specialty drugs through contract pharmacies.

Mental Health
Helps

Clinics can use 340B savings to fund more mental health services for their communities.

Small Business Owner
Helps

Independent and community pharmacies that serve as contract pharmacies benefit from continued 340B partnerships with clinics.

Key Points

  • This bill, introduced in Congress, protects a federal program that requires drug companies to sell medicine at a discount to hospitals and clinics serving low-income or rural areas. It ensures these health centers can use local and specialty pharmacies to get cheaper drugs to their patients.
  • It stops drug manufacturers from placing restrictions on where these discounted medicines are sent. This is important because many clinics do not have their own on-site pharmacies and rely on partnerships with local drugstores to make sure patients can actually pick up their prescriptions.
  • The policy is designed to help clinics stretch their limited budgets. By saving money on medicine, these health centers can afford to offer more services, like extra check-ups or mental health support, to people in their communities who might not have insurance.
  • If a drug company tries to block these discounts or refuses to ship medicine to a clinic's chosen pharmacy, they could face serious consequences. The bill allows the government to charge companies up to $2 million in fines for every day they break the rules.
  • This change is especially helpful for people with serious illnesses like cancer or multiple sclerosis. These patients often need specialty drugs that are only available through specific pharmacies, and this bill ensures the discounts apply to those life-saving medicines no matter where they are delivered.
HealthcarePrescription DrugsConsumer Protection

Milestones

2 milestones2 actions
Jul 22, 2025House

Referred to the House Committee on Energy and Commerce.

Jul 22, 2025

Introduced in House

Related News

4 articles
Axios·over 1 year ago

First Look: Senate gets a 340B pharmacy bill

Sen. Peter Welch is introducing the 340B PATIENTS Act to clarify that providers can access discounted drugs through contract pharmacies. The bill seeks to resolve a perennial source of friction between drugmakers and hospitals by codifying the right to use outside pharmacies for distribution.

C=
Applied Policy·about 2 months ago

The 340B Drug Pricing Program: Origins and Ongoing Questions

The 340B PATIENTS Act, reintroduced by Rep. Doris Matsui and Sen. Peter Welch, would prohibit manufacturers from conditioning the provision of 340B-priced drugs on the location or method of dispensing, specifically protecting contract pharmacy arrangements from industry restrictions.

C=
Politico Pro·4 months ago

Senators working toward introducing 340B reform legislation

A bipartisan group of senators is hammering out legislation to reform the 340B drug discount program. While hospitals push for protections like the PATIENTS Act to codify contract pharmacies, drugmakers argue for more guardrails to ensure discounts directly benefit low-income patients.

CL~

Source Information

Document Type

Congressional Bill

Official Title

340B PATIENTS Act of 2025

Bill NumberHR 4581
Congress119th Congress
ChamberHouse of Representatives
Latest ActionReferred to the House Committee on Energy and Commerce.

Sponsor

Cosponsors

(17)
D: 17

Analysis generated by AI. While we strive for accuracy, this should not be considered legal or professional advice. Always verify information with official government sources.